SRL
MDGL icon

Scientech Research LLC’s Madrigal Pharmaceuticals MDGL Stock Holding History

Scientech Research LLC’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$318K Buy
+592
New +$303K 0.26% 115
2025
Q4 		– Sell
-634
Closed -$291K – 687
2025
Q3 		$291K Buy
+634
New +$237K 0.1% 386
2024
Q4 		– Sell
-1,936
Closed -$411K – 744
2024
Q3 		$411K Buy
+1,936
New +$495K 0.08% 415
2024
Q1 		– Sell
-1,102
Closed -$255K – 507
2023
Q4 		$255K Buy
+1,102
New +$193K 0.25% 157

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Scientech Research LLC's MDGL Position: Q2 2026 in Review

Scientech Research LLC opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 592 shares worth $318K. The stake represents 0.26% of the portfolio and ranks #115 among its holdings. This is a return to the name: Scientech Research LLC previously reported a position in MDGL as recently as Q3 2025.

Scientech Research LLC first reported a position in MDGL in Q4 2023 and has held it in 4 quarters since. The position peaked at $411K in Q3 2024. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Scientech Research LLC held 592 shares of Madrigal Pharmaceuticals worth $318K as of Q2 2026.
  • Madrigal Pharmaceuticals was a new Scientech Research LLC position in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.26% of Scientech Research LLC's portfolio in Q2 2026, its #115 holding.
  • Scientech Research LLC first reported a position in Madrigal Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
  • Scientech Research LLC's Madrigal Pharmaceuticals position peaked at $411K in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.